arsenic has been researched along with Chromosome Deletion in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asslaber, D; Greil, R; Hamacher, F; Heyder, C; Holler, C; Merkel, O; Papak, C; Prokesch, A; Scheideler, M; Stöcher, M; Tinhofer, I; Trajanoski, Z | 1 |
| Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E | 1 |
| Cartwright, IL; Kane, D; Opoka, R; Ortiz, JG | 1 |
| Lane, AA; Ley, TJ; Pollock, JL; Walter, MJ; Westervelt, P | 1 |
| Jha, AN; Natarajan, AT; Nilsson, R; Noditi, M | 1 |
| Dabbs, ER; Sole, GJ | 1 |
1 review(s) available for arsenic and Chromosome Deletion
| Article | Year |
|---|---|
Mouse models of acute promyelocytic leukemia.
Topics: Animals; Antineoplastic Agents; Arsenic; Chromosome Deletion; Disease Models, Animal; Leukemia, Promyelocytic, Acute; Mice; Models, Biological; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Tretinoin | 2001 |
5 other study(ies) available for arsenic and Chromosome Deletion
| Article | Year |
|---|---|
Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Chromosome Deletion; Chromosomes, Human, Pair 17; Drug Resistance, Neoplasm; Enzyme Activation; Female; Free Radical Scavengers; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Oxidative Stress; Oxides; Poly(ADP-ribose) Polymerases; Prognosis; Reactive Oxygen Species; Superoxide Dismutase; Vidarabine | 2008 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid | 2017 |
Investigating arsenic susceptibility from a genetic perspective in Drosophila reveals a key role for glutathione synthetase.
Topics: Alleles; Animals; Antioxidants; Arsenic; Arsenites; Cell Survival; Cells, Cultured; Chromosome Deletion; Chromosome Mapping; Drosophila melanogaster; Female; Glutathione; Glutathione Synthase; Male; Microsatellite Repeats; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Double-Stranded; X Chromosome | 2009 |
Genotoxic effects of sodium arsenite on human cells.
Topics: Arsenic; Arsenites; Chromosome Deletion; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Humans; Micronuclei, Chromosome-Defective; Mutagenicity Tests; Mutagens; Ring Chromosomes; Sister Chromatid Exchange; Ultraviolet Rays; X-Rays | 1992 |
Plasmid-borne resistance to arsenate, arsenite, cadmium, and chloramphenicol in a Rhodococcus species.
Topics: Arsenates; Arsenic; Arsenites; Bacteriophages; Cadmium; Chloramphenicol; Chromosome Deletion; DNA, Bacterial; Mutation; Phenotype; R Factors; Rhodococcus; Transduction, Genetic; Transformation, Genetic | 1988 |